Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
about
No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.Neuroimmunological Implications of Subclinical Lipopolysaccharide from EnteritidisThe Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type DementiaCorrelative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus
P2860
Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Lipopolysaccharide-binding pro ...... nduced in Parkinson's disease.
@en
Lipopolysaccharide-binding protein
@nl
type
label
Lipopolysaccharide-binding pro ...... nduced in Parkinson's disease.
@en
Lipopolysaccharide-binding protein
@nl
prefLabel
Lipopolysaccharide-binding pro ...... nduced in Parkinson's disease.
@en
Lipopolysaccharide-binding protein
@nl
P2860
P50
P1433
P1476
Lipopolysaccharide-binding pro ...... nduced in Parkinson's disease.
@en
P2093
Sthembile Mbotwe
P2860
P304
P356
10.1371/JOURNAL.PONE.0192121
P407
P577
2018-03-01T00:00:00Z